Piozena-15

Pioglitazone Hydrochloride

Composition :Piozena - 15 Tablet : Each Film Coated Tablet Contains Pioglitazone Hydrochloride USP 15 mg.

Indications :It is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type Il diabetes (NIDDM). It also indicated for monotherapy and also indicated for use in combination with a sulfonylurea, metformin or insulin when diet and exercise plus the single agent does not result in adequate glycemic control.

Dosage and administration :Pioglitazonen can be taken once daily without regard to meals. The management of antidiabetic therapy should be individualized. Pioglitazone monotherapy in patients not adequatelycontrolled with diet and exercise may beinitiated at 15 mg or 30 mg once daily. Forpatients who respond inadequately to theinitial dose of pioglitazone,the dose can beincreased up to 45 mg once daily. Or, asdirected by the registered physicians.

Use in pregnancy &lactation :Pregnancy-There are no adequate and well controlledstudies in pregnant women. Pioglitazoneshould be used during pregnancy only if thepotential benefit justifies the potential risk to the fetus. Nursing mothers- It is not knownwhether pioglitazone is secreted in humanmilk. Because many drugs are excreted inhuman milk, it should not be administered to abreast feeding women.

Packing :Piozena -15 Tablet : Each box contains 28's, tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.